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ABSTRACT:
We have studied the molecular dynamics of one of the
major macromolecules in articular cartilage, chondroitin
sulfate. Applying 13C high-resolution magic-angle
spinning NMR techniques, the NMR signals of all rigid
macromolecules in cartilage can be suppressed, allowing
the exclusive detection of the highly mobile chondroitin
sulfate. The technique is also used to detect the
chondroitin sulfate in artificial tissue-engineered
cartilage. The tissue-engineered material that is based on
matrix producing chondrocytes cultured in a collagen gel
should provide properties as close as possible to those of
the natural cartilage. Nuclear relaxation times of the
chondroitin sulfate were determined for both tissues.
Although T1 relaxation times are rather similar, the T2
relaxation in tissue-engineered cartilage is significantly
shorter. This suggests that the motions of chondroitin
sulfate in natural and artificial cartilage are different.
The nuclear relaxation times of chondroitin sulfate in
natural and tissue-engineered cartilage were modeled
using a broad distribution function for the motional
correlation times. Although the description of the
microscopic molecular dynamics of the chondroitin
sulfate in natural and artificial cartilage required the
identical broad distribution functions for the correlation
times of motion, significant differences in the correlation
times of motion that are extracted from the model
indicate that the artificial tissue does not fully meet the
standards of the natural ideal. This could also be
confirmed by macroscopic biomechanical elasticity
measurements. Nevertheless, these results suggest that
NMR is a useful tool for the investigation of the quality of
artificially engineered tissue. # 2010 Wiley Periodicals,
Inc. Biopolymers 93: 520–532, 2010.
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INTRODUCTION
A
rticular cartilage is a connective tissue that is essen-
tial for the function of diarthrodial joints.1,2 It pro-
vides an extremely low friction surface in freely
moving joints. In addition, articular cartilage is
also a material of remarkable elastic properties. It
can sustain high pressures of up to 20 MPa that are created
from the stress and strain of exercises as well as daily tasks
such as stair climbing.3 From the physical point of view, car-
tilage is a gel of several cross-linked biopolymers that con-
tains a large fraction of water (70–80%).1,4,5 The major
macromolecules in cartilage are proteins and polysaccha-
rides. About 15–20% (by wet weight) of cartilage is collagen
(mostly type II), which provides the basic three-dimensional
architecture of the material and imposes tensile strength.4
The polysaccharides are mostly organized in proteoglycans
that contain large amounts of glycosaminoglycans (mostly
chondroitin sulfate and little keratan sulfate). Proteoglycans
make up 7–10% of the wet weight of the tissue. These
highly negatively charged macromolecules are responsible for
the swelling of cartilage and its high osmotic pressure.6 Previ-
ous work has shown that the molecules in cartilage are mo-
bile on different timescales and with varying amplitudes.7–10
Altogether, these microscopic properties determine the vis-
coelasticity of the tissue providing load bearing and shock
absorbing properties.3 In addition to the macromolecules
mentioned above, there are small leucine-rich repeat proteo-
glycans like decorin and biglycan and also a number of other
proteins that function as structural components and are
essential for morphogenesis of the extracellular matrix
(ECM) and the entire molecular architecture of cartilage.11,12
All components of the ECM are synthesized by only one cell
type, the chondrocytes, which account for about 1–5% of the
cartilage volume. A schematical sketch of the molecular
architecture in articular cartilage is shown in Figure 1A.
The molecules of the ECM of cartilage are in a constant
process of decomposition and resynthesis. Nevertheless, car-
tilage as an avascular tissue only has a very limited self-heal-
ing capacity.13–15 In particular, larger cartilage defects that
occur due to trauma or due to continuous degeneration as a
consequence of osteoarthritis or inflammatory diseases such as
rheumatoid arthritis have very limited chances to self-heal.16–18
This represents a serious socioeconomic problem in countries
with high life expectancy.19 Tissue engineering of cartilage may
represent an interesting strategy to replace diseased or worn
cartilage.20,21 To this end, chondrocytes are seeded into poly-
meric scaffolds, cultured, and stimulated to produce the typical
cartilage ECM ex vivo.21 Obviously, the artificially grown tissue
should provide the appropriate structure and properties of
native cartilage. However, three-dimensional ex vivo cartilage
tissue engineering is not a trivial problem. In vitro, both the
culture system and the growth conditions stimulate the carti-
lage forming chondrocytes to change their expression pattern,
phenotype, or biochemical properties.22
A number of physical techniques have been applied to
study the molecular architecture of cartilage. Besides nuclear
magnetic resonance (NMR) spectroscopy23,24 and magnetic
resonance imaging,24,25 for instance Fourier transformed
infrared spectroscopy (FTIR),26 atomic force microscopy
(AFM),27 and x-ray diffraction28,29 are popular methods for
studying the biophysical properties of the tissue. These tech-
niques are also well suited to investigate the macromolecules
FIGURE 1 (A) Schematic representation of the molecular archi-
tecture in articular cartilage. (B) Chemical structures of linkage
of chondroitin-4-sulfate (left) and chondroitin-6-sulfate (right).
GlcUA denotes glucuronic acid and the nomenclature of the carbon
atoms is given for one carbon ring. (C) Schematic representation of
the chondroitin sulfate linkage to the core protein of the proteogly-
can aggregates.
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in artificial cartilage to provide parameters that would char-
acterize the quality of the ex vivo-manufactured tissue. A
careful assessment of the quality of a tissue-engineered carti-
lage graft before implantation represents a crucial step for
the success of the operation.15 Most studies on tissue engi-
neering of cartilage rely on optical assays and immunohisto-
chemistry to detect the molecules of the ECM in artificial tis-
sue. Because of the extremely high sensitivity of these meth-
ods, even traces of collagen and glycosaminoglycans can be
detected. However, the parameters that determine the func-
tion of the tissue, such as elasticity and molecular mobility,
are not accessible to these techniques.
We have previously shown that solid-state NMR spectros-
copy represents a useful method to detect the tissue collagen
and characterized its internal molecular motions in carti-
lage.8,9 Further, the glycosaminoglycans of the cartilage can
be detected by NMR both in the articular7,10,30 and even in
artificial tissue.31,32 For this study, we set two objectives:
First, a quantitative analysis of the motions of the chondroi-
tin sulfate in porcine articular cartilage should be carried
out. Chondroitin sulfate is the major glycosaminoglycan in
cartilage with an approximate molecular weight of 40 kDa.
The subunit of polymeric chondroitin sulfate is a disaccha-
ride that consists of one unit of glucuronate (GlcUA) and
one unit of N-acetyl-galactosamine (GalNAc) (Figure 1B).
The GalNAc ring is either sulfated at the 4 position (chon-
droitin-4-sulfate) or the 6 position (chondroitin-6-sulfate).
We used high-resolution 13C magic-angle spinning NMR
(HR MAS NMR) to detect chondroitin sulfate as the major
glycosaminoglycan of the tissue. The other cartilage GAG,
keratan sulfate only contributes 10–15% of the GAG mono-
mers,33 which will not contribute significantly to the NMR
spectra. A motional analysis was carried out on the basis of
the relaxation times of the molecules. To describe the physi-
cal parameters of the molecular dynamics, the temperature
dependence of the relaxation times was modeled using a dis-
tribution of motional correlation times, which is often used
in polymer physics. Second, we detected the chondroitin sul-
fate in artificially engineered cartilage tissue by HR MAS
NMR. To this end, porcine chondrocytes were isolated from
full-depth articular cartilage, then subsequently seeded and
cultured in a clinically approved collagen type I hydrogel,
which is clinically applied as a scaffold for matrix-associated
chondrocyte transplantations.15 These matrices were incu-
bated under static conditions in well plate dishes that sup-
plied modified medium containing uniformly 13C-labeled
glucose as a precursor molecule to the cells. In the subse-
quent NMR experiments, we analyzed the molecular mobil-
ity of the newly formed chondroitin sulfate in the artificial
cartilage and compared it with that of the articular tissue.
Based on literature on the dynamic properties of synthetic
polymers, it is plausible that internal molecular motions in
GAG sidechains may affect the bulk mechanical properties of
cartilage. Even local motions (side-chain motions for exam-
ple) may have a significant influence on the mechanical
response of synthetic and biopolymers.34–36 However, despite
the fact that there is no study that relates the dynamics of
GAGs to the mechanical properties of cartilage, there is strong
evidence that the increase of aggrecan stiffness (in the sense of
a loss in internal mobility in the GAG sidechains) reduces the
cartilage stress relaxation and its storage module.37 Besides, a
relation between the GAG dynamics and the mechanical
properties has also been observed in other collagen-rich tis-
sues such as bovine pericardium.38 Based on these results, one
might expect that the mechanical properties of cartilage are to
some extent affected by the GAG dynamics. Although such a
relation has not been demonstrated experimentally, the NMR
results of our study point toward such a correlation and may
provide useful parameters for the comparison of natural and
artificially engineered tissue. Thus, NMR spectroscopy may
help to carry out quality control/quality assurance in tissue
engineering of cartilage and other biological tissues.
EXPERIMENTAL PROCEDURES
Materials
The hydrogel matrix CaReS
1
(Cartilage Regeneration Sys-
tem) was made from rat collagen type I fibers and supplied
by Arthro Kinetics Biotechnology GmbH (Krems an der
Donau, Austria). Collagenase A and chondroitin sulfate were
purchased from Sigma-Aldrich (Taufkirchen, Germany).
Preparation of Modified Cell Culture Medium
The chondrocyte constructs were cultured in a modified Dul-
becco’s modified Eagle medium (DMEM) with Gluta-
MAXTM-I (Gibco, Karlsruhe, Germany), in which the glucose
(4.5 g/L) was completely substituted with uniformly 13C-la-
beled glucose (Eurisotop, Saarbru¨cken, Germany). The
modified medium also contained ascorbic acid (0.05 mg/
mL), gentamycin (50 lg/mL) and 10% autologous porcine
serum (heat-inactivated at 568C). This serum was prepared
from 100 mL of blood that was initially collected in S-
Monovettes with Z-Gel (Sarstedt, Nu¨mbrecht, Germany) and
separated after 10 min of centrifugation at 2500g.
Preparation of Native Porcine Cartilage
Full-depth articular cartilage samples were initially removed
from the condylus medialis tibiae of healthy 3-month-old
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(juvenile) pigs and subsequently cut into small cubes with a
typical volume of about 1 mm3. Approximately 50 mg of the
cartilage cubes were placed in a 4-mm MAS rotor together
with a drop of D2O for the lock signal and sealed. The MAS
rotors contained an airtight Teflon insert to keep the sample
sealed and in the middle of the rotor.
Preparation of Tissue-Engineered
Cartilage Constructs
Chondrocytes were isolated from cartilage samples harvested
as above after mechanical mincing. Subsequently, enzymatic
digestion was performed with 2 mg/mL collagenase A dis-
solved in the modified DMEM. After incubation at 378C for
24 h, the chondrocyte suspension was passed through a
70-lm nylon mesh filter (Becton Dickinson, Heidelberg,
Germany). The filtrate was centrifuged at 800g for 8 min, the
supernatant removed, and the cell pellet resuspended in
DMEM. Cell seeding of the collagen hydrogel was performed
as described previously.39 Briefly, 1.5 3 106 cells were mixed
into a collagen suspension aliquot of 250 lL and subse-
quently pipetted into individual wells of a 48-well plate to
ensure uniform cylinder constructs with an initial thickness
of 3 mm and a diameter of 10 mm. After 15 min of polymer-
ization at 378C, the well plates were filled with 750 lL of the
conditioned DMEM. Constructs were transferred to larger
sample containers to ensure adequate supply with nutrients
and removal of waste and cultured under static, free swelling
conditions for 21 days at 378C, 5% CO2, and 95% humidity
with half medium changes twice a week.
Biomechanical Measurements
The average diameter, height, and wet weight of each con-
struct were measured over the course of cultivation. Com-
pressive mechanical properties of the tissue-engineered carti-
lage constructs were measured on Days 0 (i.e., freshly seeded
constructs) and 13 of cultivation. The test samples were
placed in a phosphate-buffered saline buffer-filled well plate
and were not confined circumferentially, thereby allowing
unconstrained lateral deformation during loading. Compres-
sive force was applied in 4 steps of 240-lm step size corre-
sponding to 10–40% strain using the height measurements
of the chondrocyte-loaded gel made before loading to esti-
mate the strain for the applied deformations.
13C MAS NMR Spectroscopy
All NMR experiments on natural and artificial cartilage were
carried out on a Bruker DRX600 NMR spectrometer (Bruker
Biospin, Rheinstetten, Germany) operating at a resonance
frequency of 150.8 MHz for 13C using a 4-mm HR MAS
probe. The MAS frequency was 7000 Hz. Typical 13C 908
pulse lengths were about 15 ls. Low power proton broad-
band decoupling was applied. The spectra were referenced
externally relative to trimethylsilane (TMS) as described by
Morcombe and Zilm.40 T1 and T2 relaxation times were
measured using standard inversion recovery and Carr-
Purcell-Meiboom-Gill (CPMG) pulse sequences, respectively.
To obtain decent fits for the relaxation times, eight delays
between 1 ms and 3 s or between 1 and 7 ms, respectively,
were used. For these measurements, the sample was cut into
small pieces and filled in a 4-mm MAS rotor with Teflon
insert. For each temperature, a fresh sample was prepared.
To determine the chemical shift anisotropy (CSA) of the
ring carbons of chondroitin sulfate for the analysis of relaxa-
tion rates, a two-dimensional phase-altered separation of
spinning sidebands (PASS) experiment41 was carried out for
unhydrated chondroitin sulfate powder at room temperature.
Experiments were performed at a resonance frequency of 400
MHz for 1H and 100.5 MHz for 13C with a 7-mm Varian
MAS probe with Jacobsen design. The spinning rates were
4 kHz (cross polarization [CP]) or 1 kHz (CP and PASS).
The CP contact time was 1 ms, and the relaxation delay was
5 s. At least 512 scans were recorded. The pulse length was
3.5 ls for 1H and 4.2 ls for 13C.
RESULTS
Biomechanical Measurements
First, a brief biomechanical measurement was carried out on
the tissue-engineered cartilage constructs. A typical strain-
stress diagram is shown in Figure 2. The material follows the
linear Hook’s law only in the regime of higher stress. In
the linear regime, the elasticity modulus is 17.8 kPa for the
freshly seeded scaffolds and 118.5 kPa for the artificial carti-
lage constructs. Of course, not the entire enhancement of a
factor of 6.5 is caused by the ECM provided by the chon-
drocytes since the hydrogels lose water and, therefore, an
increase in the contraction of the constructs occurs. This
contraction ends on day 13 of cultivation; therefore, the bio-
mechanical measurements were carried out immediately after
this time. During this time, the constructs lose nearly 60% of
their wet weight, which coincides with a contraction of the
diameter of 22%, whereas the height of the constructs
remains almost unaffected. Similar ratios were observed in
the literature.39 This means that the surface area is reduced
by nearly 50%. From this one could estimate an increase of
the stiffness of the constructs by a factor of 2. The differ-
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ence between this and the measured factor of 6.5 is caused by
the ECM formed by the embedded chondrocytes.
13C NMR Spectra of Natural and
Tissue-Engineered Cartilage
Figure 3 displays typical 13C MAS NMR spectra of porcine
articular cartilage (A) and the tissue-engineered cartilage
sample (B). Although previous work shows that NMR spec-
tra of nasal cartilage may not require MAS, for articular car-
tilage the application of MAS is necessary to obtain good re-
solution.30 In general, the 13C NMR spectra agree well with
what is known from literature for cartilage7,30,42 and artificial
cartilage constructs.31,32 The NMR spectra are dominated by
signals from the ring carbons of glycosaminoglycans
(between 50 and 105 ppm). At the low decoupling power
used in these experiments, no signals from collagen can be
detected. The detection of the collagen moiety requires 13C
CP MAS (CPMAS) techniques in combination with high
power decoupling.7,9,43 The line widths of the cartilage sig-
nals are typically on the order of 1 ppm, which is quite typi-
cal for samples of that kind. The comparison with a solution
NMR spectrum of pure chondroitin sulfate (C) confirms that
most signals detected in articular cartilage and the artificial
cartilage constructs are indeed due to chondroitin sulfate as
keratan sulfate is only present in low concentration in native
cartilage.7 The signal assignment for the most prominent and
well-resolved peaks is given in Table I.
In addition, the comparison of the NMR spectra also
shows some interesting differences: (i) 13C NMR cartilage
spectra exhibit some additional signals, in particular, in the
low field half of the spectrum that are likely due to small
molecules, possibly degeneration products as discussed in the
literature.44 (ii) The NMR spectrum of the artificial cartilage
construct lacks the peak at 23.7 ppm arising from the methyl
group of GalNAc. To understand this experimental observa-
tion, it should be recalled that the artificial cartilage con-
struct was cultured in a medium that contained U-13C-glu-
cose. Obviously, the good sensitivity in the detection of the
ring carbons suggests that the entire glucose ring is used as a
building block in the synthesis of the chondroitin sulfate by
the chondrocytes. Indeed, the glucuronate is directly synthe-
sized from glucose via the steps: glucose-6-P?glucose-1-
P?UDP-glucose?UDP-glucuronate.45 The GalNAc is syn-
thesized from glucose with the major intermediates: glucose-
6-P?fructose-6-P?glucosamine-6-P. The N-acetylation of
glucosamine-6-P is carried out by acetyl-coenzyme A, which
can also be formed from glucose. However, in the chondro-
cytes of the artificial cartilage constructs, the acetyl-
coenzyme A is apparently provided from an alternative
cellular source and the synthesis of GalNAc continues via
the steps: N-Ac-glucosamine-6-P?N-Ac-glucosamine-1-
P?UDP-N-Ac-glucosamine. Although the culture medium
does not only contain U-13C-glucose as the sole carbon
source, it is the most straightforward pathway to build the
disaccharides of chondroitin sulfate from the U-13C-glucose
ring, which is directly available. Interestingly, the modifica-
tions (N-acetylation) of the ring occur with natural abun-
dance 13C, i.e., are not synthesized from glucose, as previ-
ously suggested by MALDI-TOF mass spectrometry.31
FIGURE 2 Plot of the strain-stress curves of artificial collagen-
based cartilage constructs on day 0 (i.e., freshly seeded constructs,
~) and day 13 (n). The linear sectors of the curves were used to
calculate the mean equilibrium elastic modulus of the tissue. Each
point represents the mean 6 SD (n 5 3).
FIGURE 3 The 150.8-MHz 13C MAS NMR spectra of (A) native
porcine cartilage and (B) an artificial collagen-based cartilage con-
struct at a MAS frequency of 7 kHz and a temperature of 313 K. For
comparison, the solution NMR spectrum of an 8 wt% chondroitin
sulfate solution is shown (C). The peak assignment is given in Table
I; the Teflon peak arises from the rotor insert. Spectra were arbitra-
rily scaled for presentation.
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Analysis of Chondroitin Sulfate Motions
in Natural Cartilage
From the narrow line width and the good resolution of the 13C
NMR spectra discussed in the previous section, it is obvious
that the chondroitin sulfate must be highly flexible, under-
going motions with large amplitudes. The combination of
MAS and low power decoupling as applied in HR MAS is not
sufficient to average out heteronuclear dipolar couplings that
would be present in biological solids, for instance, in the colla-
gen moiety of biological tissues. Therefore, neither the tissue
collagen nor the collagen from the CaRes scaffold can be
detected by this technique (data not shown). However, HR
MAS reduces the line-broadening effects of magnetic suscepti-
bility differences in biological tissues, so that sharper NMR sig-
nals can be obtained than with conventional HR NMR techni-
ques.46 To analyze the motions of the chondroitin sulfate in
native and artificial cartilage, we measured the longitudinal
(T1) and transverse (T2) relaxation times of the molecules. All
experimental data could be fitted using single exponential
models. Relaxation times of native and tissue-engineered carti-
lage at a temperature of 208C are shown in Table I.
Nuclear relaxation is caused by stochastic fluctuations of
interaction fields caused by molecular motions. At a mag-
netic field strength of 14.1 T, the interacting fields are due to
both heteronuclear dipolar couplings between 1H and 13C
nuclei and 13C CSA. For a 13C nucleus with a single directly
bonded proton, the relaxation rates can be expressed by47:
1
T1
¼ l
2
0h
2c2Hc
2
C
64p2r6
½JðxH  xCÞ þ 3JðxCÞ þ 6JðxH þ xCÞ
þ x
2
CDr
2
3
JðxCÞ ð1Þ
1
T2
¼ l
2
0h
2c2Hc
2
C
128p2r6
½4Jð0Þ þ JðxH  xCÞ þ 3JðxCÞ þ 6JðxHÞ
þ 6JðxH þ xCÞ þ x
2
CDr
2
3
½4Jð0Þ þ 3JðxCÞ: ð2Þ
In Eqs. (1) and (2), l0 is the permeability of vacuum, h is
Planck’s constant divided by 2p, cH and cC are the gyromag-
netic ratios of 1H and 13C, respectively, r is the CH bond
length (1.1 A˚), xH and xC are the Larmor frequencies of
1H
and 13C, respectively, and Dr is the span of the static CSA
tensor of the 13C spin.
There are two unknown quantities in the equations, one is
the CSA of a given carbon, and the other is the spectral den-
sity function J(x). The 13C CSA of chondroitin sulfate was
measured in the solid state to provide its rigid limit value. In
solid-state NMR, the principal values of CSA tensors can be
determined from a Herzfeld-Berger analysis48 or simulations
of sideband intensities.49 In both approaches, slow spinning
is desired so that an adequate number of sidebands may be
analyzed. However, slow spinning leads to signal superposi-
tion in the one-dimensional NMR spectra, which compli-
cates the analysis. Figure 4 shows the 13C CPMAS NMR spec-
tra of chondroitin sulfate powder at MAS frequencies of
4 kHz and 1 kHz. Since chondroitin sulfate powder is used in
these experiments, the spectral resolution is by far not as
good as in the HR MAS NMR spectra. Obviously, the NMR
spectrum at 4 kHz shows too few sidebands for a reliable
analysis. At 1 kHz spinning, severe superposition of the
spinning sidebands prevents a quantitative analysis. To cir-
cumvent these problems, we carried out a two-dimensional
separation of the spinning sidebands using the PASS
experiment.41 As seen (Figure 4C), this approach provides
Table I Peak Assignments and Relaxation Times at 293 K of Chondroitin Sulfate in Native and Artificial Cartilage
Peak
Number
Chemical
Shift (ppm) Assignment
Native Cartilage Artificial Cartilage
T1 (ms) T2 (ms) T1 (ms) T2 (ms)
1a 104.4 C-4-S GlcUA C-1, C-6-S GlcUA C-1 632 6 95 7.1 6 1.9 949 6 30 2.7 6 0.7
2a 101.7 C-4-S GalNAc C-1, C-6-S GalNAc C-1 549 6 78 10.7 6 2.7 682 6 47 2.1 6 0.4
3a 81.1 C-4-S GlcUA C-4, C-6-S GalNAc C-3 526 6 36 12.3 6 2.2 358 6 30 9.3 6 1.0
4a 77.1 C-4-S GalNAc C-3, C-4-S GalNAc C-4,
C-4-S GlcUA C-5, C-6-S GlcUA C-5
658 6 55 10.8 6 2.7 467 6 19 8.7 6 1.4
5a 74.7 C-4-S GlcUA C-3, C-6-S GlcUA C-3 548 6 23 12.2 6 2.3 460 6 29 5.9 6 0.4
6 73.4 C-4-S GlcUA C-2, C-6-S GlcUA C-2, C-6-S GalNAc C-5 - - 430 6 27 6.5 6 0.6
7a 68.4 C-6-S GalNAc C-4, C-6-S GalNAc C-6 516 6 110 7.5 6 0.8 485 6 39 4.6 6 0.1
8 61.9 C-4-S GalNAc C-6 316 6 31 7.2 6 0.7 324 630 5.4 6 1.0
9a 52.5 C-4-S GalNAc C-2, C-6-S GalNAc C-2 532 6 173 9.1 6 1.6 274 6 25 5.0 6 0.8
10 23.7 Methyl group of N-Acetyl in GalNAc 968 6 34 17.9 6 2.1 - -
Peak numbers refer to Figure 3. The errors for the relaxation times result from the fit of the signal intensities in the relaxation experiments.
a Peaks included in the relaxation analysis.
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sidebands up to the fourth order for the ring carbons and up
to the eighth order for the carbonyl. Because the spectral re-
solution of chondroitin sulfate powder under solid-state con-
ditions is inferior to that of hydrated chondroitin sulfate in
cartilage, not all carbons of the ring can be measured. The
spans of the CSA tensor of chondroitin sulfate could be
determined for C1 (Dr 5 31 ppm), C2 (Dr 5 41 ppm), and
the peak that includes C3, C4, and C5 (Dr 5 38 ppm). Peaks
represent a combination of GlcUA and GalNAc from both
chondroitin-4-sulfate and chondroitin-6-sulfate.
The second unknown quantity in Eqs. (1) and (2) is the
spectral density function, which provides a measure of the ef-
ficiency of molecular motion at an angular rate of x for
modulating the heteronuclear dipole-dipole interaction to
cause spin relaxation. Physically, spectral density functions
are the Fourier transforms of the correlation functions that
characterize the molecular motions. Typically, analytical
models are used to simulate the molecular motions yielding
a wealth of applicable functional forms for the spectral den-
sity functions. For cartilage, two approaches have been used
in the past. For instance, a Lipari-Szabo analysis50 for the
molecular motions of chondroitin sulfate in bovine nasal car-
tilage has been employed, revealing correlation times of 30
ns for the overall and 1 ns for the internal motions, respec-
tively. The generalized order parameters were relatively low
(S2 5 0.33–0.72).51 The Lipari-Szabo approach assumes that
macromolecules undergo isotropic tumbling in solution.
Although the model allows fitting the experimental data,
it should be emphasized that the chondroitin sulfates in car-
tilage are not freely diffusing molecules in solution. Rather,
these polyelectrolytes are mounted to a more rigid core pro-
tein on one end and freely mobile on the other end. Such
molecular constraints are likely to result in a distribution of
correlation times as indicated in Figure 1C. The impact of
this geometrical constraint on NMR relaxation behavior was
first evaluated by Torchia et al.7 on a sample of bovine nasal
cartilage. These authors used a log v2 distribution function
that was also very successfully applied in polymer science at
the time.52,53 To fit the experimental relaxation times, the
authors had to apply relatively broad distribution functions
for the correlation times.
Here, we used the Kohlrausch-Williams-Watts (KWW)
distribution function for the data analysis.54 Given the charac-
teristics of the chondroitin sulfate in cartilage (long flexible
chains anchored to a rigid protein), it is very reasonable to
assume that the KWW function can be interpreted as a result
of motional heterogeneities. In this model, a nonexponential
form of the correlation function is introduced by a stretched
exponential for any given correlation time sKWW according to:
CðtÞ ¼ exp  t
sKWWðTÞ
 b !
; ð3Þ
where 0  b  1. The Fourier transform of C(t) is the spec-
tral density function that then contains a distribution func-
tion G(t) as given in Eq. (4).
FIGURE 4 The 100.5-MHz 13C CPMAS NMR spectra of chondroi-
tin sulfate studied as an amorphous powder (a combination of chon-
droitin-4-sulfate and chondroitin-6-sulfate) at a spinning rate of 4 kHz
(A) and 1 kHz (B). The asterisks indicate the spinning sidebands of the
carbonyl peak in spectrum (A). Panel C shows the two-dimensional
PASS spectrum. Measurements were recorded at room temperature.
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JðxÞ ¼
Z1
0
GðsÞs
1 þ x2s2 ds : ð4Þ
However, for the stretched exponential of the KWW func-
tion, there is no analytical solution of the distribution func-
tion, and the Fourier transform has to be done numerically;
b 5 1 indicates no distribution of correlation times as in the
case of isotropic tumbling of small molecules. Decreasing b
broadens the distribution function. The spectral density
functions are calculated as the Fourier transform of Eq. (3).
An example of the calculated distribution function is given
in Figure 6. The average (or mean) correlation time resulting
from this distribution is given by the expression:
smean ¼ sKWWb C
1
b
 
; ð5Þ
where G(x) is the gamma function. Since there is no analyti-
cal expression for these spectral density functions, the Fou-
rier transform was calculated numerically. For the tempera-
ture dependence of the correlation time sKWW, an Arrhenius
behavior was assumed:
sKWWðTÞ ¼ s0 exp EA
kBT
 
; ð6Þ
where EA is the activation energy, kB the Boltzmann constant,
and T the absolute temperature. For the simulation of the
temperature dependence of the T1 and T2 relaxation times a
self-written Fortran program was used.
The temperature dependence of the T1 and T2 relaxation
times for cartilage chondroitin sulfate and the result of the
data analysis are shown in Figure 5A–5D. The T1 values are
scattered around the minimum of the T1 curve, whereas the
T2 values increase with increasing temperature. The tempera-
ture dependence of the relaxation times could be well simu-
lated using the KWW model. Unfortunately, the biological
nature of the sample restricted the temperature range over
which relaxation can be measured without destroying the
sample. Therefore, only a few data points could be used in
the fit.
All parameters for fitting the relaxation times are shown
in Table II. The best results were obtained for b 5 0.30 6
0.01, which represents a rather broad distribution of correla-
tion times that covers more than three orders of magnitude.
It should be emphasized that the relaxation data cannot be
fitted to a model that does not consider a distribution of the
correlation times. The Dr values that were necessary to fit
the relaxation data ranged between 48 and 57 ppm for the
ring carbons of chondroitin sulfate. This is somewhat larger
than what has been measured experimentally. Nevertheless,
we believe that the PASS measurement of the dry-solid chon-
droitin sulfate provides the correct results, as the determina-
tion of this parameter indirectly by fitting relaxation rates is
more model dependent and, therefore, less reliable. The acti-
vation energies vary slightly between the different carbons of
the rings. However, the fact that similar values were obtained
for each carbon of the ring structure suggests that the inter-
nal mobility is dominated by the motions of the whole chon-
droitin sulfate polymer chain, with each carbon ring moving
more or less as an entire unit.
Analysis of Chondroitin Sulfate Motions
in Artificial Cartilage
Finally, the same relaxation times were measured for the arti-
ficial collagen-based cartilage constructs. Typical relaxation
times at a temperature of 208C are also given in Table I.
There are moderate differences in these values, suggesting
that the motional behavior for chondroitin sulfate in natural
FIGURE 5 Typical examples for the measured relaxation data
(T1-n, T2-^) and the simulations obtained with the KWW model
(solid lines) for (A)–(D) articular porcine cartilage and (E)–(H) ar-
tificial collagen-based cartilage constructs. (A, E) C-4/6-S GlcUA C-
1, Peak 1 in Figure 3; (B, F) C-4/6-S GalNAc C-2, Peak 9 in Figure
3; (C, G) C-4/6-S GlcUA C-3, Peak 5 in Figure 3; (D, H) C-4-S
GlcUA C-4, C-6-S GalNAc C-3, Peak 3 in Figure 3. The fitting pa-
rameters for the KWW model are summarized in Tables II and III.
The error bars for the relaxation times originate from the fit of the
signal intensities in the relaxation experiments.
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and artificial cartilage is different. We also applied the same
motional analysis of the temperature dependence of the
relaxation times to the data from the artificial cartilage. The
raw data and the fitting curves are shown in Figure 5E–5H.
Somewhat different parameters were used to fit the experi-
mental relaxation times of the chondroitin sulfate in the col-
lagen hydrogel as indicated by 20–50% longer correlation
times. The parameters are given in Table III. However, again,
a low b value of 0.30 6 0.01 was necessary to fit the tempera-
ture dependence of the relaxation times. This suggests that
the motional correlation times for the chondroitin sulfate
motions in the collagen scaffold are as broadly distributed as
in natural cartilage. Activation energies for the motional
processes are very similar compared with cartilage. The Dr
values that were necessary to provide a reasonable fit are
again somewhat larger for chondroitin sulfate in artificial
cartilage, which indicates the imperfections of the relaxation
model.
DISCUSSION
NMR represents a useful tool that allows for the selective
characterization of the major biopolymers of cartilaginous
tissues—glycosaminoglycans and collagen—without any pre-
treatment, enzymatic digestion, or cryopreservation. The
choice of the applied NMR method (CPMAS for the collagen
and HR MAS for the glycosaminoglycans) selects a specific
molecular species according to its molecular mobility. Thus,
the method is not only applicable in basic research to under-
stand the molecular origin of the viscoelastic properties of bi-
ological tissues but also holds potential as a tool in the qual-
ity control of artificially engineered tissues. NMR studies on
polymers and rubbers have highlighted the importance of
molecular mobility for the macroscopic elastic properties of
these materials.55–58 The extension of such studies to natural
and artificial connective tissue seems promising.
Clearly, a number of parameters influence the molecular
motions in biological tissues, which, together with the
Table II Simulation Parameters for the Temperature Dependence of the Chondroitin Sulfate Relaxation in Native Articular Cartilage
According to the KWWModel
Peak EA (kJ/mol)
a Dr (ppm)a smean (293 K) (ns)
a smax (293 K) (ns)
a
C-4-S GlcUA C-1, C-6-S GlcUA C-1 22.2 53 9.1 0.91
C-4-S GalNAc C-1, C-6-S GalNAc C-1 22.7 57 11.1 1.11
C-4-S GalNAc C-2, C-6-S GalNAc C-2 22.2 53 9.1 0.91
C-4-S GalNAc C-3, C-4-S GalNAc C-4,
C-4-S GlcUA C-5, C-6-S GlcUA C-5
21.7 48 7.4 0.75
C-4-S GlcUA C-4, C-6-S GalNAc C-3 22.2 49 9.1 0.91
C-4-S GlcUA C-3, C-6-S GlcUA C-3 21.7 50 7.4 0.75
C-6-S GalNAc C-4, C-6-S GalNAc C-6 22.2 51 9.1 0.95
For all fits, b 5 0.3 and s0 5 1 3 10
212 s were applied. The values of smean were calculated according to Eq. (5). (C-4-S – chondroitin-4-sulfate, C-6-S –
chondroitin-6-sulfate). smax is the correlation time at which G(t) is maximum.
a The typical error limits for these values are EA56 0.5 kJ/mol, Dr 56 3 ppm, smean 56 2 ns, and smax5 0.3 ns.
Table III Simulation Parameters for the Temperature Dependence of the Chondroitin Sulfate Relaxation in Artificial Cartilage
According to the KWWModel
Peak EA (kJ/mol)
a Dr (ppm)a smean (293 K) (ns)
a smax (293 K) (ns)
a
C-4-S GlcUA C-1, C-6-S GlcUA C-1 23.2 64 13.5 1.35
C-4-S GalNAc C-1, C-6-S GalNAc C-1 23.6 64 16.5 1.65
C-4-S GalNAc C-2, C-6-S GalNAc C-2 22.2 64 9.1 0.91
C-4-S GalNAc C-3, C-4-S GalNAc C-4,
C-4-S GlcUA C-5, C-6-S GlcUA C-5
22.7 64 11.1 1.11
C-4-S GlcUA C-4, C-6-S GalNAc C-3 22.7 64 11.1 1.11
C-4-S GlcUA C-3, C-6-S GlcUA C-3 22.7 64 11.1 1.11
C-6-S GalNAc C-4, C-6-S GalNAc C-6 22.7 64 11.1 1.11
For all fits, b 5 0.3 and s0 5 1 3 10
212 s were applied. The values of smean were calculated according to Eq. (5). (C-4-S – chondroitin-4-sulfate, C-6-S –
chondroitin-6-sulfate). smax is the correlation time at which G(t) is maximum.
a The typical error limits for these values are EA56 0.5 kJ/mol, Dr 56 3 ppm, smean 56 2 ns, and smax5 0.3 ns.
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osmotic characteristics and the flow of tissue liquids, deter-
mine their viscoelastic properties. These parameters include
the chain length of the respective biopolymer, the charge
density, the ionic strength, the degree of cross-linking, and
the interaction with other molecules such as collagen or
other cartilage proteins. Such a situation has to be mim-
icked as closely as possible when creating artificial tissue to
replace diseased or lost articular cartilage. In addition to a
number of biological parameters, which can be assayed by
various methods,20 an analysis of the physical properties of
the macromolecules in artificial tissue provides a compre-
hensive assessment of the quality of the artificially engi-
neered tissue.
NMR is well suited to determine some important parame-
ters that characterize the quality of tissue-engineered carti-
lage and other biological tissues and provides a number of
advantages.
i. NMR spectra provide a characteristic fingerprint of the
molecular composition of a biological tissue for analyt-
ical purposes. Typically, biological tissues are com-
posed of macromolecules that are characterized by a
number of very specific NMR signals that usually allow
for an unambiguous assignment of the molecule.
ii. Complicated NMR spectra that consist of a superposi-
tion of several signals can be separated either by mul-
tidimensional NMR or by application of mobility fil-
ters. For instance, the glycosaminoglycans of cartilage
are highly mobile and are detected using direct excita-
tion in combination with low power decoupling,
whereas the cartilage collagen is only detected if
CPMAS techniques are applied.9,43
iii. In principle, NMR spectroscopy is a quantitative
method that can be applied to determine the concen-
tration of a molecule relative to an internal standard.
Under MAS conditions, the internal standards are not
as well established as in solution NMR.40 In addition,
the 13C labeling as carried out in our study may
impose difficulties on a quantitative analysis as the
culture medium does not only contain U-13C-glucose
as a carbon source. Under these circumstances, the
quantitative analysis of the production of new ECM in
cartilage constructs is better carried out by other
assays.
iv. NMR is a method with low sensitivity. However, this
serious disadvantage means that NMR can only detect
the macromolecules in cartilage when they have been
expressed to a sizable amount. This means that NMR
does not detect traces of macromolecules in tissues
that can be easily detected by for instance optical/spec-
trophotometric or immunohistochemical assays.
However, high quality artificial tissue requires appro-
priate amounts of molecules that constitute it.
v. NMR can measure a number of motional parameters
that provide further insights into the architecture,
concentration, and interaction of the biopolymers in
the tissue. This property may be exploited to compare
natural and artificially engineered tissue. The rationale
behind this is that a similar molecular environment
for the GAG sidechains would result in similar relaxa-
tion times as the nuclear relaxation is modulated by
the stochastic dynamics of the molecules in the tissue.
Here, we probed the T1 and T2 relaxation times, which
provide a measure of the internal dynamics in the correlation
time window from tens of picoseconds up to microseconds.
The relaxation data, in particular T2, did show some signifi-
cant differences, suggesting that the artificial cartilage that
was produced does not fully resemble the natural ideal. To fit
the temperature dependence of T1 and T2 relaxation times to
a motional model, we had to apply a broad KWW distribu-
tion function. Such a distribution function is shown in Fig-
ure 6. Clearly, the correlation times are distributed over sev-
eral orders of magnitude: a value of G(s) 5 0.5 Gmax is
reached for correlation times of about 0.02 and 7.9 ns. Since
the saccharide rings will move more or less as whole units, as
suggested by the similarity of fitting parameters for the vari-
ous carbons of each ring, this distribution of correlation
times describes the quite variable mobility along the polymer
chain. Although segments close to the attachment point to
the proteoglycan aggregates would have rather long correla-
tion times, these times will decrease towards the end of the
polymer chain, where very short correlation times will occur.
FIGURE 6 Distribution function of the correlation time accord-
ing to the KWW model with the parameters b 5 0.3 and smax 5
1 ns.
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Although not proven, it is possible that this broad range of
motions contributes to the unique viscoelastic properties of
the biological cartilage. It is further known that polydis-
perse polymer melts often display stretched exponentials in
their memory function, which could also provide the ex-
planation for the observation of broad distribution func-
tions.59 It should also be noted that other relaxation mod-
els can fit the data. For instance, our data could be well fit
by the Lipari-Szabo approach, providing longer correlation
times for the artificial cartilage as well. However, as dis-
cussed above, the Lipari Szabo approach is defined for iso-
tropically tumbling proteins, which is not fully justified
considering the architecture of chondroitin sulfate in the
proteoglycans.
Although the measured relaxation times fall within the
same order of magnitude, a closer inspection reveals system-
atic differences. In particular, the T2 relaxation rates are 20–
80% shorter in artificial compared with natural cartilage,
whereas the T1 relaxation times are more randomly scattered
within 30%. This may indicate that in particular the slower
and physiologically important motions are rather different in
the two tissues. These differences are at least in part repre-
sented in our model. The calculated smean [as defined in Eq.
(5)] and smax (correlation time at which G(s) is maximum)
values for the distribution functions of the correlation time
at a temperature of 293 K are shown in Tables II and III. As
suggested by shorter T2 relaxation times, the correlation
times of the chondroitin sulfate motions are 20–50% longer
in artificial cartilage compared with the natural tissue. It is
interesting that the glycosaminoglycans in artificial cartilage
show shorter T2 relaxation times corresponding to longer
correlation times. One would expect both proteoglycans and
collagen to be less rigid in the tissue-engineered cartilage,
which is generally softer and less solid-like than the natural
tissue. This effect may be due to the different organization of
the collagen in natural cartilage as opposed to the collagen
scaffold in the artificial tissue. This can also be inferred from
recent measurements, which indicated that the quadrupolar
interaction of 23Na increases in degraded cartilage, which
would provide a similar trend as observed in our measure-
ments.24,60 Of course, degraded and artificial cartilage are
completely different tissues, but these studies are particularly
noteworthy as degradation of cartilage means that the tissue
biopolymers are destroyed and do not provide the structural
integrity, which may be similar to the situation of artificial
cartilage, where the native molecular architecture is not (yet)
present.
Therefore, we adhere to the statement that the artificial
cartilage of this study does not provide the full structural and
dynamical integrity as the natural ideal, which is already
indicated by the different NMR relaxation times. The mathe-
matical model for the relaxation times agrees with that, as
seen in the different correlation times.
The differences in the microscopic dynamical properties
of the natural and artificial tissues are also confirmed by the
biomechanical measurement, which reveals that the macro-
scopic elasticity of the artificial and natural cartilage are not
nearly close. The typical elasticity modulus of the artificial
cartilage was measured to be (118.5 6 38.5) kPa, which is
much lower than the values of 2–3 MPa that are given for
native articular cartilage.61
Interestingly, the difference in the macroscopic elastic
properties of the natural and artificial tissue appears much
more drastic than what is inferred from the NMR. Diffu-
sion NMR experiments have shown that the mesh size of
the collagenous network in cartilage is rather large. Re-
stricted diffusion was only observed for long observation
times on the order of 500 ms, which means that the mesh
size corresponds to 10 lm.62 This means that in intact
cartilage, the motions of the chondroitin sulfate should not
largely be influenced by the collagen, which agrees with the
solution like relaxation behavior we observed. Further, this
may also explain why we see shorter T2 relaxation times in
the artificial cartilage as the chondroitin sulfate motions
may be more restricted by collagen than in native cartilage.
Clearly, the NMR measurement only senses the direct vi-
cinity of the molecules studied while the elasticity measure-
ment reports the relevant bulk properties. Thus, NMR only
reports microscopic dynamic properties and cannot be sen-
sitive to voids and defects in the scaffolds, where no ECM
has been produced.
Nevertheless, there is merit in the NMR data as it provides
information about the identity and concentration of the rele-
vant matrix molecules. Further, the NMR measurement on
artificial tissue can be carried out in a noninvasive fashion,
for instance, in a NMR-compatible bioreactor. Under these
circumstances, no magic-angle spinning can be applied,
which will decrease the resolution of the NMR spectra.30
Nevertheless, static NMR experiments would provide addi-
tional information about the macromolecular orientation,
which is also an important parameter to assess the quality of
the tissue-engineered cartilage.25
Finally, it is well known that native cartilage possesses an
anisotropic structure, in which the collagen fibril thickness
and orientation as well as proteoglycan concentration varies
with depth. In contrast, tissue-engineered constructs gener-
ally lack this depth-dependent structure. Although more cells
are seeded into these constructs than are present in natural
cartilage, the expression of ECM ex vivo is rather low as also
seen in our study. Since HRMAS is not an imaging
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technique, the resulting NMR spectra represent a weighted
average of the components of the various layers in native car-
tilage specimens. This fact may perturb the simple interpreta-
tion of the relaxation properties of the biopolymers in native
cartilage from the HRMAS spectra. Further, because of the
depthwise variations in cartilage composition noted above, it
is likely that GAG internal dynamics also vary with depth in
native cartilage, which is not addressed by the HRMAS tech-
nique. Therefore, an NMR spectroscopic analysis as carried
out in this paper should be accompanied by methods that
allow for the evaluation of the anisotropic three-dimensional
architecture of cartilage, as is for instance possible by mag-
netic resonance tomography.
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